RU2020125133A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2020125133A3 RU2020125133A3 RU2020125133A RU2020125133A RU2020125133A3 RU 2020125133 A3 RU2020125133 A3 RU 2020125133A3 RU 2020125133 A RU2020125133 A RU 2020125133A RU 2020125133 A RU2020125133 A RU 2020125133A RU 2020125133 A3 RU2020125133 A3 RU 2020125133A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18154454.5 | 2018-01-31 | ||
EP18154454 | 2018-01-31 | ||
EP18183692 | 2018-07-16 | ||
EP18183692.5 | 2018-07-16 | ||
PCT/EP2019/052213 WO2019149738A1 (en) | 2018-01-31 | 2019-01-30 | Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2020125133A RU2020125133A (ru) | 2022-02-28 |
RU2020125133A3 true RU2020125133A3 (ru) | 2022-02-28 |
RU2788000C2 RU2788000C2 (ru) | 2023-01-16 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
IL276353B1 (en) | 2023-10-01 |
RU2020125133A (ru) | 2022-02-28 |
SG11202007143UA (en) | 2020-08-28 |
CA3089678A1 (en) | 2019-08-08 |
US11858927B2 (en) | 2024-01-02 |
CN111788195A (zh) | 2020-10-16 |
EP3746437A1 (en) | 2020-12-09 |
AU2019216264B2 (en) | 2023-08-31 |
JP7337813B2 (ja) | 2023-09-04 |
WO2019149738A1 (en) | 2019-08-08 |
US20210078995A1 (en) | 2021-03-18 |
JP2021514346A (ja) | 2021-06-10 |
AU2019216264A1 (en) | 2020-08-13 |
BR112020015072A2 (pt) | 2021-01-05 |
MX2020007954A (es) | 2021-01-08 |
CN111788195B (zh) | 2023-11-21 |
KR20200138166A (ko) | 2020-12-09 |
IL276353A (en) | 2020-09-30 |
IL276353B2 (en) | 2024-02-01 |
MA51889A (fr) | 2021-05-05 |
US20240116931A1 (en) | 2024-04-11 |